Credit Suisse’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2
| Closed | -$2 | – | 3879 |
|
|
2022
Q4 | $2 | Sell |
2
-235
| -99% | -$235 | ﹤0.01% | 3894 |
|
|
2022
Q3 | $1K | Buy |
237
+198
| +508% | +$835 | ﹤0.01% | 3973 |
|
|
2022
Q2 | $0 | Buy |
+39
| New | – | ﹤0.01% | 4511 |
|
|
2021
Q4 | – | Sell |
-165,863
| Closed | -$1.23M | – | 3751 |
|
|
2021
Q3 | $1.23M | Sell |
165,863
-384,699
| -70% | -$2.86M | ﹤0.01% | 2439 |
|
|
2021
Q2 | $3.74M | Buy |
550,562
+45,979
| +9% | +$313K | ﹤0.01% | 1736 |
|
|
2021
Q1 | $5.18M | Buy |
+504,583
| New | +$5.18M | ﹤0.01% | 1522 |
|
|
2018
Q3 | – | Sell |
-11,867
| Closed | -$91K | – | 3466 |
|
|
2018
Q2 | $91K | Sell |
11,867
-2,450
| -17% | -$18.8K | ﹤0.01% | 3380 |
|
|
2018
Q1 | $321K | Buy |
+14,317
| New | +$321K | ﹤0.01% | 3125 |
|
|
2017
Q4 | – | Sell |
-10,656
| Closed | -$166K | – | 3665 |
|
|
2017
Q3 | $166K | Buy |
+10,656
| New | +$166K | ﹤0.01% | 3496 |
|